EUVIMEDEUVIMED entdecken
Kohortenstudie

Diagnostic Utility of Exome Data Reanalysis After In Silico Multi‐Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study

Alexanne Cuillerier, Andrea Goodman, Chloe Lawrence, Noémie Villeneuve-Cloutier, Christine M Armour, Priya T Bhola, Danielle K Bourque, Melissa T Carter, Joanna Lazier, Sarah L Sawyer, Maha Saleh, Chitra Prasad und 6 weitere

Clinical Genetics · 2026

DOI: 10.1111/cge.70008 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Genetics, 2026. Verfasst von Alexanne Cuillerier und 17 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Epilepsy, Developmental Disabilities, Intellectual Disability, Genetic Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Genome Canada, Ontario Genomics, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a relatively common condition with genetic factors contributing significantly to its etiology. Advances in next‐generation sequencing have dramatically increased the number of known epilepsy genes, improving diagnostic capabilities and patient care. However, 50%–80% of epilepsy patients remain undiagnosed after genomic testing, which includes chromosomal microarray, multigene panels, and genome‐wide sequencing. Reanalysis of existing exome sequencing data has shown promise in increasing diagnostic yield. In this study, we reanalyzed exome sequencing data from 87 individuals with unsolved epilepsy and developmental delay or intellectual disability in Ontario, Canada. Our approach combined clinical and translational research methodologies to identify genetic variants linked to epilepsy. We obtained a diagnostic yield of 14.9%, solving 13 participants, with 11 involving known genes and two novel gene discoveries. In addition, 11 potential diagnoses were identified, suggesting that further investigation could confirm additional diagnoses. Factors such as the inclusion of additional family data, new disease‐gene associations, and technological advancements contributed to these findings. This study highlights the importance of reanalysis as a cost‐effective and timely approach to improving diagnostic yield in epilepsy associated with neurodevelopmental delay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyDevelopmental DisabilitiesIntellectual DisabilityGenetic TestingExomeHumansFemaleMaleChildChild, PreschoolExome SequencingRetrospective StudiesAdolescentGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingInfantOntarioComputer SimulationAdult

Stichwörter der Autor:innen

diagnostic yieldepilepsyexome re‐analysisintellectual disabilitynext‐generation sequencing

Autor:innen und Institutionen

  • Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Division of Metabolics and Newborn Screening, Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Division of Genetics, Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Children's Health Research Institute, London Health Sciences Centre Research Institute, London, Ontario, Canada.

ORCID-Profile: Kym M Boycott, David A Dyment

Förderung

  • Genome Canada
  • Ontario Genomics
  • CIHR
  • Ontario Research Foundation
  • Genome Alberta
  • Genome British Columbia
  • Génome Québec
  • Children's Hospital of Eastern Ontario Foundation

Zitieren

APA

Cuillerier, A., Goodman, A., Lawrence, C., Villeneuve-Cloutier, N., Armour, C. M., Bhola, P. T., Bourque, D. K., Carter, M. T., Lazier, J., Sawyer, S. L., Saleh, M., Prasad, C., Siu, V. M., Care4Rare Canada Consortium, Boycott, K. M., Hartley, T., Dyment, D. A., & Balci, T. B. (2026). Diagnostic Utility of Exome Data Reanalysis After In Silico Multi‐Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study. Clinical Genetics. https://doi.org/10.1111/cge.70008

Vancouver

Cuillerier A, Goodman A, Lawrence C, Villeneuve-Cloutier N, Armour CM, Bhola PT, et al. Diagnostic Utility of Exome Data Reanalysis After In Silico Multi‐Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study. Clinical Genetics. 2026. doi:10.1111/cge.70008

BibTeX
@article{Cuillerier2026,
  author = {Cuillerier, Alexanne and Goodman, Andrea and Lawrence, Chloe and Villeneuve-Cloutier, Noémie and Armour, Christine M and Bhola, Priya T and Bourque, Danielle K and Carter, Melissa T and Lazier, Joanna and Sawyer, Sarah L and Saleh, Maha and Prasad, Chitra and Siu, Victoria M and Care4Rare Canada Consortium, Care4Rare Canada Consortium and Boycott, Kym M and Hartley, Taila and Dyment, David A and Balci, Tugce B},
  title = {Diagnostic Utility of Exome Data Reanalysis After In Silico Multi‐Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study},
  journal = {Clinical Genetics},
  year = {2026},
  doi = {10.1111/cge.70008}
}
Kostenlos starten →